Dishman Carbogen Amcis Revenue

Dishman Carbogen Amcis had revenue of 6.82B INR in the quarter ending December 31, 2024, with 4.80% growth. This brings the company's revenue in the last twelve months to 26.50B, up 2.72% year-over-year. In the fiscal year ending March 31, 2024, Dishman Carbogen Amcis had annual revenue of 26.16B with 8.41% growth.

Revenue (ttm)

26.50B

Revenue Growth

+2.72%

P/S Ratio

1.27

Revenue / Employee

23.41M

Employees

1,132

Market Cap

33.78B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	26.16B	2.03B	8.41%
Mar 31, 2023	24.13B	2.72B	12.72%
Mar 31, 2022	21.41B	2.29B	11.96%
Mar 31, 2021	19.12B	-1.32B	-6.44%
Mar 31, 2020	20.44B	-150.00M	-0.73%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sun Pharmaceutical Industries	516.03B
Divi's Laboratories	90.78B
Cipla	267.20B
Mankind Pharma	116.41B
Apollo Hospitals Enterprise	211.46B
Zydus Lifesciences	222.47B
Aurobindo Pharma	309.22B
Alkem Laboratories	127.57B

Revenue Rankings

Dishman Carbogen Amcis News

13 days ago - Dishman Carbogen shares surge 5% after arm gets drug manufacturing licence In China - Business Upturn
15 days ago - Dishman Carbogen Amcis subsidiary receives drug manufacturing license in China - Business Upturn
6 weeks ago - Dishman Carbogen Amcis shares jump nearly 2% after board approves Rs 50 crore debenture issuance - Business Upturn
2 months ago - Q3 2025 Dishman Carbogen Amcis Ltd Earnings Call Transcript - GuruFocus
3 months ago - Dishman Carbogen subsidiary successfully completes Swissmedic inspection of its Vionnaz facility - Business Upturn

More News